Erratum to: Combined effect of hydrogen sulphide donor and losartan in experimental diabetic nephropathy in rats

The original version of this article [1] unfortunately contained mistakes to the figure legends and was missing Figure 7 (Fig. 1 here). The corrected legends are as follows:

Fig. 1.

Hemotoxylin-Eosin stained longitudinal section of kidneys (10×). a Normal control, b STZ treated group (45), c NaHS (30), d DL-p (10) + NaHS (30), e LOS, f NaHS (10) + Losartan (5)

Fig. 1 Experimental Protocol design.

Fig. 2 Effect of NaHS on blood glucose level in STZ treated rats. ^aP < 0.05 versus vehicle treated, ^bP < 0.05 versus [STZ (45)] treated group, ^cP < 0.05 versus [STZ (45) + NaHS (10)] treated group, ^dP < 0.05 versus [STZ (45) + NaHS (30)] treated group. STZ = Streptozotocin, NaHS = Sodium hydrosulphide, LOS = Losartan, DL-p = DL-propargylglycine.

Fig. 3 Effect of NaHS and losartan on Lipid Peroxidation in STZ treated rats. ^aP < 0.05 versus vehicle treated, ^bP < 0.05 versus [STZ (45)] treated group, ^cP < 0.05 versus [STZ (45) + NaHS (10)] treated group, ^dP < 0.05 versus [STZ (45) + NaHS (30)] treated group, ^eP < 0.05 versus [STZ (45) + LOS (5)] treated group. STZ = Streptozotocin, NaHS = Sodium hydrosulphide, LOS = Losartan, DL-p = DL-propargylglycine.

Fig. 4 Effect of NaHS and losartan on Reduced Glutathione in STZ treated rats. ^aP < 0.05 versus vehicle treated, ^bP < 0.05 versus [STZ (45)] treated group, ^cP < 0.05 versus [STZ (45) + NaHS (10)] treated group, ^dP < 0.05 versus [STZ (45) + NaHS (30)] treated group, ^eP < 0.05 versus [STZ (45) + LOS (5)] treated group. STZ = Streptozotocin, NaHS = Sodium hydrosulphide, LOS = Losartan, DL-p = DL-propargylglycine.

Fig. 5 Effect of NaHS and losartan on Nitrite in STZ treated rats. ^aP < 0.05 versus vehicle treated, ^bP < 0.05 versus [STZ (45)] treated group, ^cP < 0.05 versus [STZ (45) + NaHS (10)] treated group, ^dP < 0.05 versus [STZ (45) + NaHS (30)] treated group, ^eP < 0.05 versus [STZ (45) + LOS (5)] treated group. STZ = Streptozotocin, NaHS = Sodium hydrosulphide, LOS = Losartan, DL-p = DL-propargylglycine.

Fig. 6 Effect of NaHS and losartan on MABP in STZ treated rats. ^aP < 0.05 versus vehicle treated, ^bP < 0.05 versus [STZ (45)] treated group, ^cP < 0.05 versus [STZ (45) + NaHS (10)] treated group, ^dP < 0.05 versus [STZ (45) + NaHS (30)] treated group, ^eP < 0.05 versus [STZ (45) + LOS (5)] treated group. STZ = Streptozotocin, NaHS = Sodium hydrosulphide, LOS = Losartan, DL-p = DL-propargylglycine.

The missing figure can be found below, with the correct figure legend: